About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Insights from 2023 ASH Annual Meeting
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multiple Myeloma"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sigrun Thorsteinsdottir
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sigrun Thorsteinsdottir
155 views
December 14, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
19:28
Agios
Pyruvate Kinase Deficiency: Clinical Manifestations and Treatment Ap…
Feat.
K. Yotsumoto Fertrin
Myeloma
17:13
Insights from 2023 ASH Annual Meeting
Updates From ASH: The Evolving Role and Sequencing of Bispecifics an…
Feat.
A. Jakubowiak
08:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-3 Trial - Ide-Cel vs. Standard Regim…
Feat.
K. Patel
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
04:30
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-2 Extended Follow-Up - Ide-Cel in Pt…
Feat.
M. Alsina
16:42
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…
Feat.
H. Hashmi
19:24
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…
Feat.
P. Richardson
06:44
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Sonrotoclax Combined With Dexamethasone for…
Feat.
H. Quach
06:55
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Selinexor and Lenalidomide vs. Lenalidomide…
Feat.
H. Quach
05:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Teclistamab in R/R MM - A Multi-Institution…
Feat.
R. Chakraborty
15:13
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With…
Feat.
P. Richardson
09:05
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "KarMMa-3 Trial - Effects of Ide-Cel vs. Sta…
Feat.
M. Delforge
09:39
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Impact of Dex Dose Strength on Outcomes in …
Feat.
R. Banerjee
04:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Early Peripheral Blood MRD Status by NGS in…
Feat.
B. Derman
06:19
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Dara-KRd in NDMM Without ASCT - Final Analy…
Feat.
B. Derman
12:32
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Early Benefits and Psychological Effects of…
Feat.
S. Rögnvaldsson
10:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Re…
Feat.
S. Rögnvaldsson
10:53
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "RVd vs. RVd Plus ASCT in African Americans …
Feat.
J. Zonder
17:46
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies …
Feat.
A. Jakubowiak
08:36
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligi…
Feat.
N. Joseph
10:06
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Ex…
Feat.
D. Pan
06:14
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Inflammatory Biomarkers and Outcomes in MM …
Feat.
D. Pan
12:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "GMMG ReLApsE Trial - Salvage Auto Transplan…
Feat.
M. Bärtsch
10:23
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …
Feat.
T. Einarsson Long
07:27
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Dual Targeting of SLAMF-7 and CD38 - A Ph2 …
Feat.
B. Dhakal
03:14
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor,…
Feat.
J. Richter
08:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…
Feat.
R. Bansal
12:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed …
Feat.
E. Kastritis
22:14
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "RW Safety & Efficacy of Teclistamab for…
Feat.
D. Dima
09:22
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "DREAMM-6 Trial Arm-A - Belantamab Mafodotin…
Feat.
R. Popat
14:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MonumenTAL-1 Study - Talquetamab in Pts Wit…
Feat.
A. Jakubowiak
06:06
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D…
Feat.
S. Bal
04:55
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering …
Feat.
S. Thorsteinsdottir
07:20
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and …
Feat.
O. Nadeem
10:36
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies…
Feat.
O. Nadeem
11:55
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy &…
Feat.
O. Landgren